SOLARA

What Solara Active Pharma Sciences promised, and what happened

Every commitment management made on a call, tracked from the quarter it was made — reaffirmed, revised, diluted or quietly dropped.

Guidance record · Q1 FY27

what the last two calls moved 20 tracked 2 delivered 6 missed 12 open
  • Deferred Sales Recovery delivered said Q2 FY26 Promised: Service the business in next two quarters (Q3/Q4) Q1 FY27: Promise was achieved in Q3 FY26. No further updates.
  • FY26 Revenue Growth missed said Q1 FY26 Promised: around 10% Q1 FY27: The promise pertains to the completed FY26 and remains missed. No further updates.
  • CRAMS Equity Infusion Plan delayed said Q1 FY26 Promised: More answers... in the next call Q1 FY27: The decision remains linked to the Ibuprofen strategy. Management has pushed the timeline for a full plan, stating 'you will have to give us time till our Q2 results are out'.

The rest of the ledger

Above is what the last two calls moved. Pro opens all 20 tracked commitments for Solara Active Pharma Sciences — every quarter's revision, the source quote behind each one, and the topics management has stopped answering.

See what Pro opens